Reduction of postoperative adhesions after laparoscopic gynecological surgery with Oxiplex/AP Gel

A pilot study

Phil Young, Alan Johns, Claire Templeman, Craig Witz, Bobby Webster, Roger Ferland, Michael Peter Diamond, Kathleen Block, Gere DiZerega

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Objective: To determine whether Oxiplex/AP Gel (FzioMed, San Luis Obispo, CA) was safe and preliminarily effective in reducing postsurgical adhesions after adnexal surgery by laparoscopy. Design: Prospective, multicenter, double-blind, randomized, U.S. Food and Drug Administration-monitored feasibility study. Setting: University and private clinics. Patient(s): Patients undergoing laparoscopic surgery with pelvic adhesions, tubal occlusion, endometriosis, and/or dermoids were randomized to receive Oxiplex/AP Gel or no further treatment after surgery. Intervention(s): A blinded, parallel-group design was conducted at six centers. Patients (aged 18-46 years) underwent laparoscopic surgery, with second-look surgery 6-10 weeks later. Surgeries were videotaped. Oxiplex/AP Gel was used to cover adnexa and adjacent tissue. Main Outcome Measure(s): Blinded reviews of videotapes were quantitated with the American Fertility Society adhesion score (AFS score). Result(s): In 18 treatment patients, surgery was performed on 29 adnexa. Application of Oxiplex/AP Gel required approximately 90 seconds. In 10 control patients, surgery was performed on 18 adnexa. The mean baseline AFS score for each group was 8.0. At second look, treated adnexa had the same score (8.1), whereas in control adnexa the score increased (from 8.0 to 11.6). Thirty-four percent of treated adnexa increased in adhesion score, in contrast to 67% of control adnexa. There were no device-related adverse events. Conclusion(s): In this pilot study, Oxiplex/AP Gel was safe, easy to use with laparoscopy, and produced a reduction in the increase of adnexal adhesion scores.

Original languageEnglish (US)
Pages (from-to)1450-1456
Number of pages7
JournalFertility and sterility
Volume84
Issue number5
DOIs
StatePublished - Nov 1 2005

Fingerprint

Gynecologic Surgical Procedures
Laparoscopy
Gels
Fertility
Second-Look Surgery
Tubal Sterilization
Dermoid Cyst
Videotape Recording
Feasibility Studies
Endometriosis
United States Food and Drug Administration
Outcome Assessment (Health Care)
Oxiplex
Equipment and Supplies
Therapeutics

Keywords

  • Adhesions
  • Oxiplex/AP Gel
  • Surgery

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Reduction of postoperative adhesions after laparoscopic gynecological surgery with Oxiplex/AP Gel : A pilot study. / Young, Phil; Johns, Alan; Templeman, Claire; Witz, Craig; Webster, Bobby; Ferland, Roger; Diamond, Michael Peter; Block, Kathleen; DiZerega, Gere.

In: Fertility and sterility, Vol. 84, No. 5, 01.11.2005, p. 1450-1456.

Research output: Contribution to journalArticle

Young, P, Johns, A, Templeman, C, Witz, C, Webster, B, Ferland, R, Diamond, MP, Block, K & DiZerega, G 2005, 'Reduction of postoperative adhesions after laparoscopic gynecological surgery with Oxiplex/AP Gel: A pilot study', Fertility and sterility, vol. 84, no. 5, pp. 1450-1456. https://doi.org/10.1016/j.fertnstert.2005.04.055
Young, Phil ; Johns, Alan ; Templeman, Claire ; Witz, Craig ; Webster, Bobby ; Ferland, Roger ; Diamond, Michael Peter ; Block, Kathleen ; DiZerega, Gere. / Reduction of postoperative adhesions after laparoscopic gynecological surgery with Oxiplex/AP Gel : A pilot study. In: Fertility and sterility. 2005 ; Vol. 84, No. 5. pp. 1450-1456.
@article{c49e482b08ed48d6bda9de52341ca2d9,
title = "Reduction of postoperative adhesions after laparoscopic gynecological surgery with Oxiplex/AP Gel: A pilot study",
abstract = "Objective: To determine whether Oxiplex/AP Gel (FzioMed, San Luis Obispo, CA) was safe and preliminarily effective in reducing postsurgical adhesions after adnexal surgery by laparoscopy. Design: Prospective, multicenter, double-blind, randomized, U.S. Food and Drug Administration-monitored feasibility study. Setting: University and private clinics. Patient(s): Patients undergoing laparoscopic surgery with pelvic adhesions, tubal occlusion, endometriosis, and/or dermoids were randomized to receive Oxiplex/AP Gel or no further treatment after surgery. Intervention(s): A blinded, parallel-group design was conducted at six centers. Patients (aged 18-46 years) underwent laparoscopic surgery, with second-look surgery 6-10 weeks later. Surgeries were videotaped. Oxiplex/AP Gel was used to cover adnexa and adjacent tissue. Main Outcome Measure(s): Blinded reviews of videotapes were quantitated with the American Fertility Society adhesion score (AFS score). Result(s): In 18 treatment patients, surgery was performed on 29 adnexa. Application of Oxiplex/AP Gel required approximately 90 seconds. In 10 control patients, surgery was performed on 18 adnexa. The mean baseline AFS score for each group was 8.0. At second look, treated adnexa had the same score (8.1), whereas in control adnexa the score increased (from 8.0 to 11.6). Thirty-four percent of treated adnexa increased in adhesion score, in contrast to 67{\%} of control adnexa. There were no device-related adverse events. Conclusion(s): In this pilot study, Oxiplex/AP Gel was safe, easy to use with laparoscopy, and produced a reduction in the increase of adnexal adhesion scores.",
keywords = "Adhesions, Oxiplex/AP Gel, Surgery",
author = "Phil Young and Alan Johns and Claire Templeman and Craig Witz and Bobby Webster and Roger Ferland and Diamond, {Michael Peter} and Kathleen Block and Gere DiZerega",
year = "2005",
month = "11",
day = "1",
doi = "10.1016/j.fertnstert.2005.04.055",
language = "English (US)",
volume = "84",
pages = "1450--1456",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Reduction of postoperative adhesions after laparoscopic gynecological surgery with Oxiplex/AP Gel

T2 - A pilot study

AU - Young, Phil

AU - Johns, Alan

AU - Templeman, Claire

AU - Witz, Craig

AU - Webster, Bobby

AU - Ferland, Roger

AU - Diamond, Michael Peter

AU - Block, Kathleen

AU - DiZerega, Gere

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Objective: To determine whether Oxiplex/AP Gel (FzioMed, San Luis Obispo, CA) was safe and preliminarily effective in reducing postsurgical adhesions after adnexal surgery by laparoscopy. Design: Prospective, multicenter, double-blind, randomized, U.S. Food and Drug Administration-monitored feasibility study. Setting: University and private clinics. Patient(s): Patients undergoing laparoscopic surgery with pelvic adhesions, tubal occlusion, endometriosis, and/or dermoids were randomized to receive Oxiplex/AP Gel or no further treatment after surgery. Intervention(s): A blinded, parallel-group design was conducted at six centers. Patients (aged 18-46 years) underwent laparoscopic surgery, with second-look surgery 6-10 weeks later. Surgeries were videotaped. Oxiplex/AP Gel was used to cover adnexa and adjacent tissue. Main Outcome Measure(s): Blinded reviews of videotapes were quantitated with the American Fertility Society adhesion score (AFS score). Result(s): In 18 treatment patients, surgery was performed on 29 adnexa. Application of Oxiplex/AP Gel required approximately 90 seconds. In 10 control patients, surgery was performed on 18 adnexa. The mean baseline AFS score for each group was 8.0. At second look, treated adnexa had the same score (8.1), whereas in control adnexa the score increased (from 8.0 to 11.6). Thirty-four percent of treated adnexa increased in adhesion score, in contrast to 67% of control adnexa. There were no device-related adverse events. Conclusion(s): In this pilot study, Oxiplex/AP Gel was safe, easy to use with laparoscopy, and produced a reduction in the increase of adnexal adhesion scores.

AB - Objective: To determine whether Oxiplex/AP Gel (FzioMed, San Luis Obispo, CA) was safe and preliminarily effective in reducing postsurgical adhesions after adnexal surgery by laparoscopy. Design: Prospective, multicenter, double-blind, randomized, U.S. Food and Drug Administration-monitored feasibility study. Setting: University and private clinics. Patient(s): Patients undergoing laparoscopic surgery with pelvic adhesions, tubal occlusion, endometriosis, and/or dermoids were randomized to receive Oxiplex/AP Gel or no further treatment after surgery. Intervention(s): A blinded, parallel-group design was conducted at six centers. Patients (aged 18-46 years) underwent laparoscopic surgery, with second-look surgery 6-10 weeks later. Surgeries were videotaped. Oxiplex/AP Gel was used to cover adnexa and adjacent tissue. Main Outcome Measure(s): Blinded reviews of videotapes were quantitated with the American Fertility Society adhesion score (AFS score). Result(s): In 18 treatment patients, surgery was performed on 29 adnexa. Application of Oxiplex/AP Gel required approximately 90 seconds. In 10 control patients, surgery was performed on 18 adnexa. The mean baseline AFS score for each group was 8.0. At second look, treated adnexa had the same score (8.1), whereas in control adnexa the score increased (from 8.0 to 11.6). Thirty-four percent of treated adnexa increased in adhesion score, in contrast to 67% of control adnexa. There were no device-related adverse events. Conclusion(s): In this pilot study, Oxiplex/AP Gel was safe, easy to use with laparoscopy, and produced a reduction in the increase of adnexal adhesion scores.

KW - Adhesions

KW - Oxiplex/AP Gel

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=27644565048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644565048&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2005.04.055

DO - 10.1016/j.fertnstert.2005.04.055

M3 - Article

VL - 84

SP - 1450

EP - 1456

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -